Truist Financial Corp 9 Meters Biopharma, Inc. Transaction History

Truist Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$0.52 - $1.0 $90,740 - $174,500	-174,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $104 - $150	-100 Reduced 0.06%	174,500 $192,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $146,664 - $377,136	174,600 New	174,600 $204,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.